Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of exercise on pharmacodynamics and pharmacokinetics of unfractionated heparin
2023-000150-20Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Feb 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of heparin in deep vein thrombosis (DVT) and venous thromboembolism (VTE) (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Incremental activated partial thromboplastin time (aPTT) change. Started Feb 2023; status: completed.
02
Drugs
heparin
03
Conditions
deep vein thrombosis (DVT)venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2023-000150-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-000150-20.